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Background: Few healthcare-associated infection (HAI) studies focus on risk of HAI at
the point of admission. Understanding this will enable planning and management of care
with infection prevention at the heart of the patient journey from the point of
admission.
Aim: To determine intrinsic characteristics of patients at hospital admission and extrinsic
events, during the two years preceding admission, that increase risk of developing HAI.
Methods: An incidence survey of adults within two hospitals in NHS Scotland was under-
taken for one year in 2018/19 as part of the Evaluation of Cost of Nosocomial Infection
(ECONI) study. The primary outcome measure was developing any HAI using recognized
case definitions. The cohort was derived from routine hospital episode data and linkage to
community dispensed prescribing data.
Findings: The risk factors present on admission observed as being the most sig-
nificant for the acquisition of HAI were: being treated in a teaching hospital,
increasing age, comorbidities of cancer, cardiovascular disease, chronic renal fail-
ure and diabetes; and emergency admission. Relative risk of developing HAI
increased with intensive care unit, high-dependency unit, and surgical specialties,
and surgery <30 days before admission and a total length of stay of >30 days in the
two years to admission.
Conclusion: Targeting patients at risk of HAI from the point of admission maximizes the
potential for prevention, especially when extrinsic risk factors are known and managed.
This study proposes a new approach to infection prevention and control (IPC), identifyingaledonian University, Cowcaddens Road, Glasgow G4 0BA, UK. Tel.: þ44 (0)1413 313536.
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S. Stewart et al. / Journal of Hospital Infection 114 (2021) 32e42 33those patients at greatest risk of developing a particular type of HAI who might be
potential candidates for personalized IPC interventions.
ª 2021 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.Introduction and Control (ECDC) HAI case definitions [4]. DenominatorHealthcare-associated infections (HAIs) are a threat to
patient safety; they affect patients in all healthcare settings
contributing significantly to morbidity and mortality and cost of
care [1,2]. Multiple factors contribute to risk of HAI including
ageing population, complexity of therapies and emergence of
antibiotic-resistant bacteria [3].
HAI describes multiple infection types that can affect any
organ; these infections range from urinary tract infections to
bloodstream infections (BSIs) [4]. Risk factors for these vary,
and as the incidence of HAI at the hospital population level is
relatively low, specific infection prevention and control (IPC)
measures should be targeted at individuals at increased risk of
developing particular HAIs. Identifying and understanding
potential risk factors is an essential step in reducing individual
risk of developing HAI. Risk factors include intrinsic charac-
teristics of the patient and extrinsic risk factors or exposures
that happen to patients during their hospital treatment. Many
risk factors have been described for specific populations, for
example intensive care unit (ICU) patients’ risk of pneumonia
[5e14]. However, these studies are by nature retrospective and
include risks encountered by patients until the point that they
develop HAI. Patient-centred care relies on the identification
of high-risk patients on admission in order to enable effective
IPC measures to be instigated from the outset. Whereas some
studies have focused on extrinsic risk factors and others looked
at point-of-transfer risks, some studies report whole-hospital
data and a range of HAI types and risks [5,15e18]. Cheng
et al. used a model analysing data from electronic patient
records in Taiwan, recording intrinsic and extrinsic risk factors
throughout the patient stay [18]. They proposed that this could
be developed in future to identify patients at risk throughout
their stay. This study reports a simpler approach to identify
patients at increased risk of HAI on admission. A recent sys-
tematic review identified a wide range of intrinsic and extrinsic
risk factors and concluded that there was a need to identify
patients who are most at risk of HAI, in order to maximize
patient safety [19].
This study aimed to assess the relative risk of developing
the most frequently occurring HAI types in hospitals. The risk
factors included are based on information that would be
available on admission and could potentially be used to tailor
interventions to manage specific patient risk of HAI. They
include a combination of intrinsic and extrinsic factors to
which patients have been exposed in the two years before
their current admission.Methods
Study design
The Evaluation of Cost of Nosocomial Infection (ECONI)
study was an observational incidence surveillance study. The
primary outcome measure was HAI defined by the interna-
tionally recognized European Centre for Disease Preventiondata were collected via routine data sets and linked to the
primary data collected on patients who developed HAI. A full
list of data items obtained from routine data sets is shown in
Appendix Table A2.
Setting
This study was undertaken within a teaching hospital and a
general hospital in Scotland for one year ending June 2019.
These settings were selected as being broadly representative
of other acute hospitals in Scotland in terms of patient spe-
cialties, distribution of elective, emergency and transfers,
mean length of stay, HAI prevalence, patient mix and rurality.
For the two selected hospitals there were 107,244 inpatient
admissions in 2014e15 when the study was being planned
[20,21]. During the study period the large teaching hospital had
981 beds including 25 intensive care beds (16 general, and nine
cardiothoracic), and 33 high-dependency beds (13 general,
eight cardiothoracic, and 12 transplant and renal). The large
general hospital had 492 beds including five intensive care and
four high-dependency beds [22,23].
Participants
All adult overnight inpatient admissions were included
within the denominator. Patients admitted as a day case to a
study hospital or treated in accident and emergency and dis-
charged without overnight admission were excluded.
Data collection
ECDC HAI epidemiological case definitions were used to
define HAI as outcome variable [4]. ECONI study research
nurses employed within the participating hospitals reviewed all
positive reports from the hospital microbiology databases each
day, which highlighted patients with suspected HAI. The
patient information systems were then reviewed to establish
whether the suspected cases met the ECDC HAI case defi-
nitions. These data sources included: patient management
systems (TrakCare); prescribing systems; IC (infection control)
net; medical and nursing notes; and direct observation. Cases
meeting the ECDC HAI case definitions were recorded on a
bespoke REDCap database [24,25]. This incidence data set
included: hospital, HAI type, date of onset, causative organ-
ism, and antibiotic susceptibilities, along with the patients’
Community Health Index number (CHI) [22]. CHI is the unique
identifier for all patients registered for healthcare in NHS
Scotland and was used to link patient records from routine data
sources to the denominator record. The CHI number recorded
by the ECONI research nurses was used to identify HAI cases
within the incidence cohort and all admissions were classified
as HAI admissions and non-HAI admissions. HAI admissions
contained one or more episodes of HAI. The selection of
covariates was based on risk factors identified for developing
HAI in a systematic review and meta-analysis [19].
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The denominator for the incidence cohort study was all
hospital stays containing one or more episodes of care in a
study hospital within the study period, and was identified from
Scottish Morbidity Records ‘SMR01’. This data set includes
dates and durations of all admissions and discharges to acute
hospitals [21].
Data on all eligible inpatients included: date of admission
and discharge, specialty, diagnosis for admission (International
Classification of Diseases, 10th Revision: ICD-10), surgery
defined by Office of Population Censuses and Surveys Classi-
fication of Surgical Operations and Procedures (OPCS)-4.8 in
two years before admission and during admission, number and
location of episodes of care, pre-admission outpatient
attendances and surgical interventions in the year before
admission [26,27]. The Scottish Index of Multiple Deprivation
(SIMD) 2016 quintiles for Scotland were mapped to the National
Records of Scotland (NRS) 2019 Scottish Postcode Directory and
linked using the SMR01 patient postcode [28]. Charlson
Comorbidity Index (CCI) values were calculated using ICD-10 V4
codes from all available SMR01 diagnosis fields, and scores
divided into mild (1e2), moderate (3e5), and severe (6)
categories for analysis [29,30]. A bespoke specialty group was
derived using a combination of significant facility of treatment
and specialty of consultant caring for the patients. These
groups were high-dependency unit (HDU); intensive care unit
(ICU); medicine (MED); obstetrics and gynaecology (OBGYN);
all surgical specialties were combined (SUR). A bespoke group
of comorbidities was derived based on the ICD-10 codes within
SMR dataset. These included diabetes ICD-10 codes (E08eE14);
chronic renal failure (CRF) (N17eN19); cardiovascular disease
(I00eI99); cancers/malignant neoplasms (C00eC96); chronic
pulmonary disease (COPD) (J40eJ47); and nervous system
diseases (G00eG99). These all referred to admissions prior to
the admission episode analysed in the study.
The number of outpatient hospital visits and any outpatient
procedures within the year preceding their admission to hos-
pital were taken from the SMR00 data set, which records out-
patient attendances [31]. Linkage to community dispensed
prescribing via the ‘Prescribing Information System for Scot-
land’ (PIS) provided information on antibiotic exposure in the
year before admission [32]. Details of all of the risk factors
included in the model are outlined within the Supplementary
Appendix. Antibiotic exposure refers to all community dis-
pensed antibiotics and is expressed as the cumulative number
of defined daily doses (DDDs) dispensed in the year before
admission [33]. Time from when the last antibiotic was taken to
admission was calculated. The date corresponding to the end
of the antibiotic course was estimated by adding the number of
DDDs to the dispensed date, and time to admission calculated
in days as the duration from the end of course to admission.
Time was set to zero where admission occurred before the
estimated last day of taking the antibiotic.
Statistical methods
Each hospital stay contributed once to the analysis. A
patient who was readmitted within the study period could
contribute more than one stay to the denominator. Admissions
with an onset of HAI on or before the date of admission or a
date of onset of HAI that did not occur within an inpatient staywere excluded. Episode records within the SMR01 data set were
created when a patient was discharged. Patients who remained
in hospital at the time of the analysis would not yet have
generated a discharge record and were also excluded. Linkage
to the routine data sets was undertaken 90 days after the end
of the study data collection period to allow for the time lag in
data being available for analysis. Records with no valid CHI (N¼
10) could not be linked and were excluded. Where a patient’s
admission contained more than one HAI, the first HAI was used
to group the HAI type. The data, sourced from SMR01, were
largely complete as these are mandatory data fields that
are recorded for all patients [34]. SIMD was linked using
patient postcode; where this was missing (N ¼ 340) SIMD was
categorized as ‘unknown’.
Thirty-two potential risk factors were included within the
analysis, and were based on biological plausibility and pre-
viously proposed factors within the existing literature [19,20].
This initial set of factors was included within a series of uni-
variate analyses to identify predictors significantly associated
with developing HAI. A test for trend was performed for con-
tinuous variables by comparing a linear regression model con-
taining the only variable on its own against the null (intercept
only) model using likelihood ratio test. No linear trends were
identified. Backwards stepwise model selection was performed
to identify those risk factors associated with HAI at the 5% sig-
nificance level. Statistical significance of individual variables
was evaluated using Wald’s test, and likelihood ratio tests were
used to compare nested models in the model build procedure.
A sequential approach was developed when building the
model. Risk factors were split into three conceptual themes for
modelling to help focus selection: m1, demographics; m2,
factors pertaining to the denominator stay; and m3, factors
pertaining to the period before admission to the denominator
stay. The models were run sequentially, with m2 consisting of
those factors identified in the m1 best-fitting model plus
additional m2 factors, and m3 consisting of those factors
identified in the m2 best-fitting model plus additional m3 fac-
tors. Details of the factors included within each model are
described in detail in Appendix Table A2. The version retained
for multivariate modelling was identified via the lowest Akaike
information criterion (AIC) score from the previous best-fitting
adjusted model. The factors included within the final model
were then used within an adjusted analysis to evaluate the
relative risk of the six most frequently occurring HAI types. A
multinomial model was run to investigate the relative risk of
developing six specific HAI types. All statistical analysis was
performed using R software (version 3.5.1) [35].Ethics
This study was surveillance and therefore was confirmed as
ineligible for ethical review (Bailey A. Personal communication
to S. Stewart, September 8th, 2016. South East Scotland
Research Ethics Service). It was approved by national infor-
mation governance approvals: Public Benefit of Health and
Social Care: Incidence study: 1617-0037.Results
During the study period there were a total of 99,018 adult
overnight admissions. After the application of statistical
63,890 admissions treated within study
hospital during study period with LOS >1
day
Excludes
17 HAI records that did not link*
10 invalid CHI
7 valid CHI with no SMR01 record




Figure 1. CONSORT diagram for inpatient stays included within the cohort study risk analysis. *Ten patients did not have valid Community
Health Index number (CHI; non-Scottish residents), seven patients had no Scottish Morbidity Records (SMR01) available (still in hospital or
transcription error). LOS, length of stay; HAI, healthcare-associated infection.
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to the study hospitals during the study period. There were
44,399 for the teaching hospital and 19,491 for the general
hospital (Figure 1). A total of 893 admissions had one or more
HAI, with 822 in the teaching hospital and 71 within the gen-
eral hospital. Overall incidence was 1.4% with 1.9% within the
teaching hospital and 0.4% in the general hospital (reported
elsewhere [36]).
Table I shows the numbers and percentage of the risk factors
included in the final multivariate model within these inpatient
stays. Patients aged >60 years made up 61% of admissions.
There were similar numbers of males and females. More than
half of the admissions had been admitted to hospital at least
once in the preceding two years (54.5%) and more than one-
tenth (12.8%) were patients who had been in hospital for >30
days in the preceding two years. SIMD category two (second
most deprived quintile) was the most frequently occurring
(26.3%). More than three-quarters of admissions (77.9%) were
emergency admissions. Descriptive frequencies and percen-
tages of all potential risk variables included in the analysis are
shown in Appendix Table A1.
Table I shows the unadjusted and adjusted relative risk (RR)
and 95% confidence interval (CI). Comparing within variable
groups, patients admitted to a general hospital had sig-
nificantly lower risk of developing HAI compared with those in
the teaching hospital. Risk of developing HAI increased with
age, with those aged >80 years showing an RR of 2.47 (CI:
1.82e3.40) compared with those aged <40 years. The highest
risk, adjusted for the effects of all other risk factors, was
admission to an ICU specialty compared with general medicine
(RR: 4.11; 95% CI: 3.34e5.02). This was followed by admission
to an HDU specialty (RR: 2.70; 95% CI: 2.08e3.47) compared
with a general medical specialty, those with chronic renal
failure (RR: 2.19; 95% CI: 1.88e2.54) compared with those
without the condition and emergency admissions compared
with elective (RR: 2.0; CI: 1.64e2.46). There was an increased
risk associated with surgeries within 30 days prior to admis-
sion (RR: 1.86; 95% CI: 1.49e2.32), and prior hospital stays of
more than two weeks during the previous two years (1.37; 95%
CI: 1.08e1.73 for 15e30 days; increasing to RR: 1.65; 95% CI:
1.34e2.04 for >30 days).
Despite showing no association at this point of analysis, sex
was retained throughout the analysis as it was considered a
clinically important patient characteristic, and later was
shown to relate to specific HAI types. Patients in the two least
deprived SIMD categories were less likely to develop HAI during
their hospital stay than those in the most deprived.Table II shows the adjusted risk by HAI type. There was a
reduced risk of onset of any HAI type during a stay in the
general hospital compared with the teaching hospital, although
the small numbers in the general hospital studied, when ana-
lysed by infection type, may reduce the power to accurately
detect associations for some infections.
For BSI the strongest associations were seen in patients
previously diagnosed with chronic renal failure (RR: 4.73; 95%
CI: 3.38e6.63) and cancer (3.24; 2.14e4.91), in emergency
admissions (3.38; 1.97e5.79) or admission to HDU specialty,
and an increased risk with age. BSI showed an increased risk
(2.86; 1.31e6.25) in those aged >70 years relative to those
aged <40 years.
Gastrointestinal infection (GI) also showed an increased
risk in those aged >70 years, and in patients aged >80 years
the risk was a factor of 5.22 (95% CI: 2.18e12.47) greater than
that of those aged <40 years. Emergency admissions showed a
2.36 increase in RR (CI: 1.26e4.43). Patients with diabetes,
chronic renal failure, and cancer all showed an increased risk
of GI along with those with hospital stays of more than one
week in the two years preceding denominator admission.
Patients with total length of stay (LOS) >8 days in the two
years before admission had an increased RR of GI infection;
patients with LOS >30 days had three times greater risk (3.07;
1.79e5.28) than patients with no hospital stay in the previous
two years.
There was an increased risk of lower respiratory tract
infections (LRI) (RR: 9.86; 95% CI: 6.54e14.88) and pneumonia
(19.56; 10.92e35.02) in those with an ICU admission. HDU
patients had an increased risk relative to medical patients of
LRI and pneumonia 3.53 (2.01e6.18) and 4.63 (1.90e11.30)
respectively. Age showed less of an effect on relative risk of
developing LRI or pneumonia. Total length of stay >30 days in
the preceding two years was significant for both LRI (1.98;
1.17e3.35) and pneumonia (3.56; 1.68e7.55).
Although there was some evidence of a reduced risk in the
intermediate compared with most deprived SIMD categories for
those with a surgical site infection (SSI), there was no clear
linear trend. There was an increased risk of SSI associated with
time from last surgery to admission, with those having surgery
within the 30 days before admission having a risk 6.28 times
that of those not having surgery. There was no clear pattern
observed in associations with time from surgery for other HAI
types. Patients who had recent surgery are at increased risk of
developing SSI on a subsequent admission. This is greatest
during the first 30 days after surgery (RR: 6.28; 95% CI:
3.60e10.95) but an increased risk is shown in the period from
Table I
Demographics, univariate and multivariate risk ratios, and potential confounding variables for HAI within the final multivariate model









Hospital (first study hospital in stay) Teaching 44,399 (69.5) 822 (1.9) 1 1
General 19,491 (30.5) 71 (0.4) 0.20 (0.15e0.25) 0.16 (0.12e0.20)
Age group (years) <40 9252 (14.5) 53 (0.6) 1 1
40e49 6105 (9.6) 65 (1.1) 1.86 (1.30e2.67) 1.59 (1.11e2.29)
50e59 9638 (15.1) 137 (1.4) 2.48 (1.81e3.40) 1.97 (1.44e2.74)
60e69 11,540 (18.1) 157 (1.4) 2.37 (1.74e3.24) 1.76 (1.29e2.44)
70e79 13,451 (21.1) 222 (1.7) 2.88 (2.14e3.88) 2.19 (1.62e3.01)
80 13,904 (21.8) 259 (1.9) 3.25 (2.42e4.36) 2.47 (1.82e3.40)
Sex Male 30,145 (47.2) 442 (1.5) 1 1
Female 33,745 (52.8) 451 (1.3) 0.91 (0.80e1.04) 1.03 (0.90e1.17)
SIMD (1: most deprived; 5: least
deprived)
1 12,705 (19.9) 177 (1.4) 1 1
2 16,824 (26.3) 271 (1.6) 1.16 (0.96e1.40) 1.05 (0.88e1.27)
3 12,088 (18.9) 157 (1.3) 0.93 (0.75e1.15) 0.84 (0.68e1.04)
4 10,338 (16.2) 124 (1.2) 0.86 (0.69e1.08) 0.74 (0.59e0.93)
5 11,595 (18.1) 160 (1.4) 0.99 (0.80e1.22) 0.77 (0.62e0.95)
Unknown 340 (0.5) 4 (1.2) 0.84 (0.32e2.26) 0.85 (0.26e1.97)
Cancer (denominator stay) No 59,206 (92.7) 780 (1.3) 1 1
Yes 4684 (7.3) 113 (2.4) 1.83 (1.51e2.23) 1.72 (1.40e2.09)
Cardiovascular disease (denominator
stay)
No 39,566 (61.9) 425 (1.1) 1 1
Yes 24,324 (38.1) 468 (1.9) 1.79 (1.57e2.04) 1.40 (1.22e1.62)
Chronic renal failure (denominator
stay)
No 56,278 (88.1) 621 (1.1) 1 1
Yes 7612 (11.9) 272 (3.6) 3.24 (2.81e3.73) 2.19 (1.88e2.54)
Diabetes (denominator stay) No 57,385 (89.8) 748 (1.3) 1 1
Yes 6505 (10.2) 145 (2.2) 1.71 (1.43e2.04) 1.26 (1.05e1.51)
Admission type (denominator stay) Elective 14,149 (22.1) 125 (0.9) 1 1
Emergency 49,741 (77.9) 768 (1.5) 1.75 (1.45e2.11) 2.00 (1.64e2.46)
Specialty (admission to first study
hospital in denominator stay)
MED 35,158 (55.2) 387 (1.1) 1 1
HDU 1764 (2.7) 71 (4.2) 3.66 (2.85e4.69) 2.70 (2.08e3.47)
ICU 2761 (4.2) 124 (4.7) 4.08 (3.35e4.98) 4.11 (3.34e5.02)
OBGYN 1774 (2.8) 12 (0.7) 0.61 (0.35e1.09) 1.21 (0.63e2.08)
SUR 22,433 (35.1) 299 (1.4) 1.21 (1.04e1.41) 1.67 (1.43e1.96)
Time since last surgery (days to
admission)
Nonea 35,656 (55.8) 406 (1.1) 1 1
30 4523 (7.1) 135 (3.0) 2.62 (2.16e3.18) 1.86 (1.49e2.32)
31e90 5250 (8.2) 105 (2.0) 1.76 (1.42e2.17) 1.29 (1.01e1.62)
91e180 5026 (7.9) 82 (1.6) 1.43 (1.13e1.81) 1.19 (0.92e1.52)
181 13,435 (21.0) 165 (1.2) 1.08 (0.90e1.29) 0.96 (0.79e1.17)
Total length of stay in 2 years to
admission (days)
0 29,083 (45.5) 307 (1.1) 1 1
1e2 6763 (10.6) 82 (1.2) 1.15 (0.90e1.46) 1.11 (0.86e1.42)
3e7 8231 (12.9) 86 (1.0) 0.99 (0.78e1.26) 0.85 (0.66e1.09)
8e14 5681 (8.9) 94 (1.7) 1.57 (1.25e1.97) 1.19 (0.93e1.52)
15e30 5978 (9.4) 119 (2.0) 1.89 (1.53e2.33) 1.37 (1.08e1.73)
>30 8154 (12.8) 205 (2.5) 2.38 (2.00e2.84) 1.65 (1.34e2.04)
HAI, healthcare-associated infection; RR, relative risk; CI confidence interval; IMD, Scottish Index of Multiple Deprivation. Bespoke specialties: HDU,
high-dependency unit; ICU, intensive care unit; MED, medicine; OBGYN, obstetrics and gynaecology; SUR, all surgical specialties.
The full tables including factors not included within the final multivariate model are available in the Supplementary Appendix.
a Patients did not have a surgery as defined by Office of Population Censuses and Surveys Classification of Surgical Operations and Procedures
within the two years preceding the admission.
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 32e423631e90 days (2.75; 1.45e5.21). It is important to note that the
cohort study analysis did not include surgery within the current
admission.
Urinary tract infection (UTI) showedan increasedRRwithage,
with those aged>80 years having five times the risk of those aged<40years (RR: 5.13; 95%CI: 2.26e11.65).Therewas an increased
risk inemergency comparedwithelective admissions for patients
with UTI. There was 67% increased risk of UTI onset during a
hospital stay in females compared with males. This was the only
HAI type which showed an increased RR for either sex.
Table II
Adjusted risk ratios (95% confidence intervals) for the risk of developing one of six HAI types during an inpatient stay in hospital, based on the multivariate final model
Variable Group BSI GI LRI PN SSI UTI
Hospital (first study
hospital in stay)
Teaching 1 1 1 1 1 1
General 0.11 (0.06e0.21) 0.02 (0.01e0.10) 0.01 (0.00e0.08) 0.10 (0.03e0.26) 0.47 (0.30e0.75) 0.19 (0.12e0.31)
Age group (years) <40 1 1 1 1 1 1
40e49 1.55 (0.60e4.06) 2.84 (1.08e7.52) 1.72 (0.76e3.86) 2.23 (0.66e7.55) 0.94 (0.40e2.24) 1.67 (0.60e4.63)
50e59 2.09 (0.91e4.78) 1.92 (0.73e5.04) 2.10 (1.01e4.36) 2.76 (0.90e8.49) 1.72 (0.86e3.44) 2.71 (1.13e6.50)
60e69 2.13 (0.95e4.78) 1.93 (0.75e4.93) 1.49 (0.71e3.14) 2.37 (0.77e7.29) 1.26 (0.62e2.60) 2.95 (1.26e6.94)
70e79 2.86 (1.31e6.25) 2.58 (1.05e6.37) 1.93 (0.93e3.99) 2.01 (0.63e6.35) 1.81 (0.91e3.61) 3.56 (1.55e8.18)
80 2.33 (1.05e5.18) 5.22 (2.18e12.47) 1.85 (0.87e3.93) 2.87 (0.91e9.07) 0.96 (0.43e2.14) 5.13 (2.26e11.65)
Sex Male 1 1 1 1 1 1
Female 0.87 (0.63e1.19) 0.84 (0.60e1.19) 0.87 (0.63e1.20) 0.95 (0.60e1.51) 0.88 (0.61e1.28) 1.67 (1.23e2.26)
SIMD (1: most deprived; 5:
least deprived)
1 1 1 1 1 1 1
2 1.35 (0.85e2.15) 1.22 (0.75e2.01) 1.17 (0.73e1.88) 0.91 (0.48e1.74) 0.78 (0.48e1.25) 0.96 (0.64e1.46)
3 0.96 (0.56e1.63) 0.85 (0.47e1.51) 1.07 (0.64e1.80) 1.19 (0.62e2.28) 0.50 (0.28e0.91) 0.75 (0.47e1.21)
4 0.81 (0.45e1.44) 0.96 (0.54e1.71) 0.77 (0.43e1.39) 0.65 (0.29e1.44) 0.54 (0.30e0.97) 0.64 (0.38e1.06)
5 0.95 (0.56e1.60) 0.75 (0.42e1.32) 0.94 (0.55e1.59) 0.48 (0.21e1.09) 0.57 (0.32e1.02) 0.80 (0.51e1.25)
Unknown 1.49 (0.20e11.17) 1.64 (0.22e12.34) 1.66 (0.38e7.25) - - -
Cancer (denominator stay) No 1 1 1 1 1 1
Yes 3.24 (2.14e4.91) 1.72 (1.03e2.89) 2.19 (1.33e3.59) 1.87 (0.92e3.80) 0.84 (0.45e1.57) 1.32 (0.79e2.21)
Cardiovascular disease
(denominator stay)
No 1 1 1 1 1 1
Yes 1.39 (0.99e1.94) 0.68 (0.47e0.98) 1.21 (0.85e1.72) 1.47 (0.87e2.48) 2.02 (1.34e3.02) 2.23 (1.63e3.07)
Chronic renal failure
(denominator stay)
No 1 1 1 1 1 1
Yes 4.73 (3.38e6.63) 2.18 (1.49e3.18) 2.20 (1.53e3.17) 1.51 (0.87e2.63) 1.59 (0.98e2.58) 1.92 (1.37e2.70)
Diabetes (denominator stay) No 1 1 1 1 1 1
Yes 1.18 (0.77e1.81) 1.64 (1.05e2.56) 1.80 (1.19e2.70) 0.76 (0.36e1.62) 0.79 (0.44e1.42) 1.15 (0.76e1.76)
Admission type
(denominator stay)
Elective 1 1 1 1 1 1
Emergency 3.38 (1.97e5.79) 2.36 (1.26e4.43) 1.02 (0.66e1.59) 1.56 (0.79e3.10) 1.88 (1.19e2.96) 2.91 (1.79e4.74)
Specialty (admission to first
study hospital in
denominator stay)
MED 1 1 1 1 1 1
HDU 2.90 (1.65e5.08) 1.70 (0.82e3.52) 3.53 (2.01e6.18) 4.63 (1.90e11.30) 11.18 (4.06e30.79) 1.38 (0.60e3.23)
ICU 1.40 (0.69e2.86) 1.44 (0.61e3.39) 9.86 (6.54e14.88) 19.56 (10.92e35.02) 17.90 (7.59e42.21) 1.23 (0.61e2.49)
OBGYN 1.21 (0.28e5.20) e 0.37 (0.05e2.79) 1.36 (0.17e10.77) 22.43 (6.96e72.31) 1.75 (0.52e5.87)
SUR 1.81 (1.26e2.60) 0.75 (0.49e1.16) 0.63 (0.39e1.03) 1.07 (0.53e2.16) 19.28 (9.58e38.79) 2.04 (1.48e2.80)
Time since last inpatient
surgery (days to
admission)
Nonea 1 1 1 1 1 1
30 1.70 (0.99e2.94) 1.80 (1.03e3.15) 0.68 (0.34e1.38) 1.66 (0.78e3.53) 6.28 (3.60e10.95) 1.53 (0.88e2.66)
31e90 0.97 (0.52e1.80) 1.26 (0.70e2.25) 0.81 (0.44e1.50) 1.19 (0.54e2.62) 2.75 (1.45e5.21) 1.42 (0.84e2.42)
91e180 1.08 (0.57e2.04) 1.40 (0.78e2.51) 1.15 (0.65e2.05) 0.67 (0.25e1.83) 1.38 (0.63e3.03) 1.42 (0.82e2.43)
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Identifying patients who are at greater risk of developing
HAI at the start of their hospital stay and managing their care to
optimize infection prevention is critical. HAI in the hospital
population is a relatively infrequent event, with less than 2% of
admissions developing HAI during their stay within the ECONI
study [36]. This measure of disease frequency is only useful if it
can be used to prevent HAI following admission to hospital.
Extrinsic risk factors, such as clinical device insertion, are well
established in the literature but illustrated only a small pro-
portion of all infections in the ECONI study [36]. Previous
studies have tended to focus on specific HAIs, types, causative
organisms, or risk factors [19]. However, identifying risk factors
that are known at the start of a patient’s admission is more
valuable because this allows targeted IPC measures to be
implemented early [3]. This study provides a novel whole-
hospital analysis of the factors that increase the risk of HAI,
and individual HAI types at the point of admission. The findings
have important implications for hospital IPC strategy nationally
and locally. This should inform targeting interventions to
patients in selected specialties, with the greatly increased risk
of developing HAI or a particular HAI type. The opportunity to
undertake these types of analyses is rare as data collection is
intensive and costly.
The greatest risk factors for development of any HAI were:
being treated in a teaching hospital, increasing age, emergency
admission and comorbidities of cancer, cardiovascular disease,
chronic renal failure, and diabetes. There are differences in
teaching and general hospitals in terms of severity of illness of
patients and complexity of treatments provided for those
patients. Previous studies have shown there to be a higher risk
of infection in larger teaching hospitals [37e39]. Comparisons
tend to focus on the difference in prevalence of HAI between
acute care, combining general and teaching hospitals and pri-
mary care combining community and long-stay hospitals
[20,40]. Whole-hospital incidence studies are rare and a pre-
vious study within the UK focused on a single general hospital
[41]. Many of these factors have featured in similar studies to
date. However, hospital presentation and socioeconomic sta-
tus have not been identified in the latest systematic review and
require further research [19]. This may be because previous
studies have not considered risk for all HAIs at the point of
admission, but have retrospectively considered all risks for the
entire inpatient stay. Further, the focus of many papers con-
tinues to be on those risk factors that are modifiable, rather
than considering how best to manage those factors, from an IPC
perspective, which cannot be modified.
Hospital type and specialty are an important consideration
for prioritizing organizational IPC resources based on risk [42].
In addition, consideration of the historical patient pathway to
the current admission is essential. Patients with more than 15
days total stay in hospital, during the two years before their
current admission, made up 22.2% of all admissions and those
with >30 days were 12.8% of all admissions. Patients at risk of
readmissions are linked to long-term conditions and frailty, or
emergency admission in younger patients [43]. Previous studies
have found that length of stay in older medical patients was
related to functional status score, illness severity, cognitive
score, poor nutrition, comorbidity score, diagnosis or pre-
senting illness, polypharmacy, age, and gender [44]. With the
S. Stewart et al. / Journal of Hospital Infection 114 (2021) 32e42 39move from hospital care to managing patients with complex
needs in the community, there is clear potential for reduction
in both number and length of hospital stay to reduce risk of HAI.
Most studies of HAI identify age as a risk factor, in line with
the findings here. Older adults are vulnerable to a range of
adverse events within the hospital setting compared with
younger patients, including malnutrition and pressure ulcers
[45e48]. These patients have an increased incidence of
comorbidities [49], multiple drugs, and impaired motor and
sensory and immune function [50,51]. In line with previous
studies, older age increased the relative risk for BSI, GI, and UTI
[15,52e54]. The increasing risk of HAI with age, especially in
those aged >70 years, points to a need for risk assessment for
HAI at point of admission, particularly given the projected 34%
increase in the population aged75 years by 2030 in the UK and
what this means for risk of HAI and need for refocused IPC in
hospitals [55]. For example, specific interventions, that may
appear costly prevention measures if implemented at a whole-
hospital level, could be targeted to a group of patients who are
known to be vulnerable to infection and who have poorer
outcomes if they develop HAI.
Multimodal prevention of UTI e the HAI type on which the
effect of age is greatest e has been a focus for some years in
the form of care bundles for all catheterized patients [56].
There has been a great deal of research into device-related UTI
over the last 10 years, especially in relation to antimicrobial
materials used in catheters; and although evidence exists for
efficacy, there is very limited literature on the cost-
effectiveness of infection prevention interventions [57,58].
Despite the increased cost of these specialized IPC measures, if
overall numbers of infections are reduced significantly and
their use is limited to patients who are likely to benefit the
most, it is possible that they may well be cost-effective [59].
There is a considerable overlap in the factors predicting
extended LOS and risk of HAI, many of which contribute to
overall frailty of the patient. Incidence, bed-day use and cost
of HAI are often compared with other diseases in the literature,
showing that cancers, cardiovascular diseases, and diabetes
achieve greater recognition and funding than HAI, when HAI is a
similar burden [60]. However, this study has shown that such a
‘comparative approach’ is a rather simplistic way of looking at
the problem [60,61]. The patients with these conditions are the
very same patients who are most at risk of HAI.
This study has shown that, for several HAI types, the factors
affecting development of HAI that could be identified on
admission include some data not currently routinely available
to clinical teams. A potential limitation of this risk factor
analysis, and of national data sets more broadly, is the exclu-
sion of devices present on admission as a risk factor. However,
this is likely to be a small proportion of all admissions to hos-
pital. There is a need for further development of current
patient management systems in order to fully achieve this
potential. In order to develop the potential for risk assessment
on admission, we recommend that hospital admission systems
not only include the risk factors identified within this study but
in addition record devices in situ. This study demonstrates the
potential of creating risk assessment tools on admission, if
these data are available, for identifying those most at risk of
HAI and prioritizing additional IPC measures in their care
pathways to mitigate that risk.
The ECONI surveillance study included all patient admissions
to the study hospitals. The two hospitals selected toparticipate in the study represent about 10% of annual admis-
sions to acute Scottish hospitals. The patient population is
similar to the overall NHS Scotland population [21]. Limited
identifiable data were recorded for the study; only CHI number
was used to divide the cases and non-cases into two groups.
This reduced recruitment bias, but resulted in exclusion of
those not resident in Scotland (0.1% of all admissions). Charlson
comorbidity score data showed that 35.6% of patients did not
have a previous admission to derive a CCI score, and that the
overall comorbidity summary was not as strong a predictor as a
set of individual comorbidities.
In conclusion, this study used a large cohort design to identify
and quantify risk of HAI based on factors that are known at point
of admission. Most previous studies examined retrospective risk
based on cumulative factors that occur during the hospital stay.
These findings may help develop a clinical decision tool to
identify patients at greatest risk of developing a particular type
of HAI. These patients would be potential candidates for per-
sonalized infection prevention interventions.Acknowledgements
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